111 related articles for article (PubMed ID: 22129514)
1. Angiotensin II receptor activation in youth triggers persistent insulin resistance and hypertension--a legacy effect?
Togashi N; Maeda T; Yoshida H; Koyama M; Tanaka M; Furuhashi M; Shimamoto K; Miura T
Hypertens Res; 2012 Mar; 35(3):334-40. PubMed ID: 22129514
[TBL] [Abstract][Full Text] [Related]
2. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
Zhou MS; Schulman IH; Raij L
J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.
Su Q; Qin DN; Wang FX; Ren J; Li HB; Zhang M; Yang Q; Miao YW; Yu XJ; Qi J; Zhu Z; Zhu GQ; Kang YM
Toxicol Appl Pharmacol; 2014 Apr; 276(2):115-20. PubMed ID: 24576725
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase.
Wei Y; Sowers JR; Clark SE; Li W; Ferrario CM; Stump CS
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E345-51. PubMed ID: 18073321
[TBL] [Abstract][Full Text] [Related]
7. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
[TBL] [Abstract][Full Text] [Related]
8. Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats.
Ran J; Hirano T; Adachi M
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E955-61. PubMed ID: 15213064
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger.
Touyz RM; Yao G
Clin Sci (Lond); 2003 Aug; 105(2):235-42. PubMed ID: 12725644
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
[TBL] [Abstract][Full Text] [Related]
11. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets.
Pech V; Sikka SC; Sindhu RK; Vaziri ND; Majid DS
Am J Hypertens; 2006 May; 19(5):534-40. PubMed ID: 16647629
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
Strawn WB
Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
[TBL] [Abstract][Full Text] [Related]
14. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats.
Togashi N; Ura N; Higashiura K; Murakami H; Shimamoto K
J Hypertens; 2000 Nov; 18(11):1605-10. PubMed ID: 11081773
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.
Zhou MS; Liu C; Tian R; Nishiyama A; Raij L
Cardiovasc Diabetol; 2015 May; 14():45. PubMed ID: 25928697
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension.
Zhao W; Swanson SA; Ye J; Li X; Shelton JM; Zhang W; Thomas GD
Hypertension; 2006 Oct; 48(4):637-43. PubMed ID: 16940212
[TBL] [Abstract][Full Text] [Related]
17. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat.
Wei Y; Whaley-Connell AT; Chen K; Habibi J; Uptergrove GM; Clark SE; Stump CS; Ferrario CM; Sowers JR
Hypertension; 2007 Aug; 50(2):384-91. PubMed ID: 17533199
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II inhibits glucose uptake of skeletal muscle via the adenosine monophosphate-activated protein kinase pathway.
Shinshi Y; Higashiura K; Yoshida D; Togashi N; Yoshida H; Miyazaki Y; Ura N; Shimamoto K
J Am Soc Hypertens; 2007; 1(4):251-5. PubMed ID: 20409857
[TBL] [Abstract][Full Text] [Related]
19. Bilirubin exerts renoprotective effects in angiotensin II-hypertension.
LeBlanc RM; Navar LG; Botros FT
Am J Med Sci; 2010 Aug; 340(2):144-6. PubMed ID: 20588179
[TBL] [Abstract][Full Text] [Related]
20. Synergetic antioxidant and vasodilatory action of carbon monoxide in angiotensin II - induced cardiac hypertrophy.
Kobayashi A; Ishikawa K; Matsumoto H; Kimura S; Kamiyama Y; Maruyama Y
Hypertension; 2007 Dec; 50(6):1040-8. PubMed ID: 17923586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
